AbbVie Inc. (ETR:4AB)
194.40
-1.80 (-0.92%)
At close: Dec 5, 2025
AbbVie Revenue
AbbVie had revenue of $15.78B USD in the quarter ending September 30, 2025, with 9.10% growth. This brings the company's revenue in the last twelve months to $59.64B, up 7.40% year-over-year. In the year 2024, AbbVie had annual revenue of $56.33B with 3.71% growth.
Revenue (ttm)
$59.64B
Revenue Growth
+7.40%
P/S Ratio
6.76
Revenue / Employee
$1.08M
Employees
55,000
Market Cap
343.47B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 56.33B | 2.02B | 3.71% |
| Dec 31, 2023 | 54.32B | -3.74B | -6.44% |
| Dec 31, 2022 | 58.05B | 1.86B | 3.30% |
| Dec 31, 2021 | 56.20B | 10.39B | 22.69% |
| Dec 31, 2020 | 45.80B | 12.54B | 37.69% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Merck KGaA | 21.27B |
| Siemens Healthineers AG | 23.38B |
| Bayer Aktiengesellschaft | 45.87B |
| Fresenius SE & Co. KGaA | 22.45B |
| Sartorius Aktiengesellschaft | 3.52B |
| Fresenius Medical Care AG | 19.64B |
| Carl Zeiss Meditec AG | 2.18B |
| Fielmann Group AG | 2.42B |
AbbVie News
- 1 day ago - AbbVie Inc at Piper Sandler Healthcare Conference Transcript - GuruFocus
- 2 days ago - Could Buying AbbVie Today Set You Up for Life? - The Motley Fool
- 2 days ago - How Strong Is AbbVie's Immunology Franchise After Humira's LOE? - Nasdaq
- 2 days ago - AbbVie Inc. (ABBV) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript - Seeking Alpha
- 3 days ago - Notable ETF Inflow Detected - XLV, JNJ, ABBV, MRK - Nasdaq
- 4 days ago - ABBV Quantitative Stock Analysis - Nasdaq
- 4 days ago - AbbVie to Feature New Data at ASH 2025 Showcasing Continued Advances Across Novel Treatment Modalities in Multiple Blood Cancers - PRNewsWire
- 4 days ago - 2 Top Dividend Stocks to Buy Now and Hold For a Decade - The Motley Fool